Sponsor
Clalit Health Services
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Clalit Health Services appears in 32 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
32 shownImproving Physical Activity Levels in the Arabic- Speaking Residents of East Jerusalem With PrediabetesNCT03821220 · lead sponsor · 2019-02-15
UNKNOWNFinancial Incentives for Low Socioeconomic Diabetic PatientsNCT03506230 · lead sponsor · 2018-11-25
UNKNOWNEvaluation of Social Skills Intervention on Cognitive Function in SchizophreniaNCT02134418 · lead sponsor · 2015-03-01
UNKNOWNIdentifying Patients With the COPD-Asthma Overlap Phenotype: Therapeutic ImplicationsNCT02985814 · lead sponsor · 2015-02-04
COMPLETEDImproving Adherence and Commitment to Treatment in Diabetic PatientsNCT02530840 · lead sponsor · 2014-07-01
UNKNOWNEmpowerment and Support for the Diabetic PatientNCT02179385 · lead sponsor · 2014-06-01
UNKNOWNMoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without DiabetesNCT02545062 · lead sponsor · 2014-05-01
UNKNOWNComparison of the Prediction Derived by the Cardiovascular Performance Reserve Index With the Clinical EvaluationNCT01796704 · lead sponsor · 2013-02-01
UNKNOWNFeasibility Assessment of the Aquadex FlexFlowTM Ultrafiltration System in Treating Non Hospitalized Heart Failure Patients in Dedicated Heart Failure CentersNCT01654926 · lead sponsor · 2012-12-01
COMPLETEDComputer-based Cognitive Training for Parkinson DiseaseNCT01121627 · lead sponsor · 2010-07-01
COMPLETEDEffect of Vitamin D Supplementation on Fasting Glucose and Interleukin-10 (IL-10) in Arab Women With Impaired Fasting GlucoseNCT00877123 · lead sponsor · 2009-06-01
COMPLETEDThe Impact of the PACE Program Implementation on Health Services Utilization by Obese Arab WomenNCT00827424 · lead sponsor · 2008-12-01
COMPLETEDAssociations Between Diabetes Care and Haptoglobin Genotype On outComesNCT00872456 · lead sponsor · 2005-03-01
COMPLETEDEvaluating Family & Community-Based Interventions to Improve Treatment Adherence in Metabolic Health Among Negev Bedouins (EFIT-BED)NCT06575465 · collaborator · 2024-09-01
RECRUITINGImproving Adherence to COPD Treatments in Primary CareNCT07104136 · collaborator · 2025-11-20
ENROLLING_BY_INVITATIONSelf-Management Behaviors of Arabs and Jews With Parkinson's Disease and Their Associations With Health OutcomesNCT05209698 · collaborator · 2021-05-15
UNKNOWNGut Microbiome and Gestational Diabetes MellitusNCT02649374 · collaborator · 2016-02-01
COMPLETEDDiabetes Lifestyle Assessment and Educational ToolsNCT01858506 · collaborator · 2014-08-01
COMPLETEDDiabetes Prevention in Prediabetic PatientsNCT01659697 · collaborator · 2012-08-01
UNKNOWNObservational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid ArthritisNCT01579006 · collaborator · 2012-05-01
COMPLETEDPerceptions of Exceptional Patients in Cancer Care Relating to Their Unusual SurvivalNCT02055313 · collaborator · 2012-05-01
COMPLETEDConstructed Intervention by Home and School Diabetes Nurse Visits on Diabetic Control of Children With Type I DiabetesNCT01382459 · collaborator · 2011-07-01
UNKNOWNA Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line TherapyNCT01174563 · collaborator · 2011-05-23
COMPLETEDThe Impact of Exercise Training on Functional Capacity in Heart FailureNCT01288365 · collaborator · 2011-03-01
UNKNOWNA Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDSNCT01149057 · collaborator · 2010-10-01
COMPLETEDPredictors of Future Type 2 Diabetes Mellitus in Circassians Minority in IsraelNCT01311401 · collaborator · 2009-10-01
UNKNOWNComprehensive Disease Management Program in Chronic Obstructive Pulmonary Disease (COPD) Patients in the CommunityNCT00982384 · collaborator · 2009-10-01
COMPLETEDA Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to MetforminNCT00684528 · collaborator · 2008-06-01
UNKNOWNEndothelial Function in a Sample Group of Patients From the ICARE StudyNCT00314379 · collaborator · 2006-04-01
COMPLETEDHaptoglobin Phenotype and Cardiovascular Complications in Diabetic PatientsNCT00448487 · collaborator · 2005-04-01
COMPLETEDPrevention of Cardiovascular Complications in Diabetic Patients With Vitamin E TreatmentNCT00220831 · collaborator · 2005-04-01
TERMINATEDDietary Interventions in Type 2 Obese Diabetic Patients in the CommunityNCT00520182 · collaborator · 2004-03-01
UNKNOWNDrugs studied in this sponsor's trials
2 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Clalit Health Services as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
placebo1
tocilizumab1
Sponsor roles
collaborator19
lead sponsor13
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.